State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT06580145 Phase 2
Recruiting
Leucine in Midlife Depression
Condition
Major Depression
Enrollment
75 pts
Location
United States
Sponsor
Emory University
NCT05701865 N/A
Recruiting
Biphasic Effects of Acute Alcohol Intoxication on Bystander Intervention
Condition
Alcohol Intoxication
Enrollment
192 pts
Location
United States
Sponsor
Georgia State University
NCT06602271 Phase 3
Recruiting
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Condition
Postoperative Pain, Acute
Enrollment
320 pts
Location
United States
Sponsor
Ensysce Biosciences
NCT04930653 Phase 2
Recruiting
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermi...
Condition
Folliculotropic Mycosis Fungoides
Enrollment
34 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06987526 N/A
Recruiting
Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Preventi...
Condition
Alcohol Use Disorder (AUD)
Enrollment
30 pts
Location
United States
Sponsor
University of Georgia
NCT05998135 Phase 2
Recruiting
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Condition
Ovarian High Grade Serous Adenocarcinoma
Enrollment
28 pts
Location
United States
Sponsor
Emory University
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
NCT00378924 N/A
Recruiting
Cardiology Biobank Registry
Condition
Cardiovascular Disease
Enrollment
12,000 pts
Location
United States
Sponsor
Emory University
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05784246 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to ...
Condition
Ulcerative Colitis
Enrollment
60 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06370182 N/A
Recruiting
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funne...
Condition
Acute Ischemic Stroke From Large Vessel Occlusion
Enrollment
327 pts
Location
United States, France, Hungary
Sponsor
Anaconda Biomed S.L.
NCT06429280 N/A
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Condition
Amblyopia
Enrollment
500 pts
Location
United States
Sponsor
Luminopia
NCT05243966 N/A
Recruiting
Myriad™ Augmented Soft Tissue Reconstruction Registry
Condition
Abdominal Wound Dehiscence
Enrollment
800 pts
Location
United States
Sponsor
Aroa Biosurgery Limited